Vesselon
Manufacturing · Connecticut, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
101 Merritt 7, Norwalk, Connecticut, 068...Phone Number
(203) 989-0500Website
www.vesselon.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Vesselon
Vesselon specializes in developing patentable drug co-formulations that enhance the efficacy of therapeutic drugs through the use of FDA-approved lipid microspheres and self-assembling liposomes. Their innovative platform allows drug firms to extend the lifecycle of existing drugs, grow market share, and enable new indications without altering the original drug formulation. With a focus on improving drug delivery and reducing side effects, Vesselon aims to revolutionize drug development and lifecycle management. Their technology is supported by extensive preclinical trials and a low-risk regulatory path, making it an attractive option for pharmaceutical companies.Explore more
Vesselon Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vesselon your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Vesselon is spiking on competitors!
Click to see if Vesselon had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Vesselon, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Vesselon
Funding: Get notified immidiatlly once Vesselon has new funding data
Earning: See what the market has to say on Vesselon recently announced quarterly report
Product Launch: Get notified when Vesselon launches new products
Check if Vesselon has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Vesselon
Find more new buyers
Compare Similar Companies to Vesselon
Compare insights from companies similar to Vesselon, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vesselon is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vesselon is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vesselon.
Vesselon Tech Stack
A closer look at the technologies used by Vesselon
Vesselon News & Media
Vesselon Introduces the First On-site Co-formulation Platform that Dramatically Improves How Cells Receive and Act on Drugs
By extending patents, the co-formulation and ultrasound activation at the clinic helps drug companies better manage product life cycles, protect franchises, differentiate their portfolios, and generate an endless stream of blockbusters. GREENWICH, Conn., Aug. 28, 2023 /PRNewswire/ --...Vesselon Discovery Protects and Expands Drug Franchises
Drug maker is seeking strategic relationship to deliver unprecedented levels of efficacy by making tissues more receptive to drugs. GREENWICH, Conn., May 22, 2023 /PRNewswire/ -- In a major development, Vesselon has discovered how to protect a superior method of delivering drugs shown to...Merck Preclinical Study Reports 658% Increase in STING Agonist to Tumor When Used in Combination with Vesselon's Drug
NORWALK, Conn., Sept. 22, 2021 /PRNewswire/ -- A preclinical study, authored by Merck & Co., Inc. in collaboration with Vesselon, Inc., and published in Advanced Therapeutics in September 2021, reported a new, safe method for STING agonist delivery other than the limiting intratumoral...Immuno-oncology Innovator Vesselon Expands its Portfolio with Patented Technology to Enable Systemic Viral Therapy with Microspheres and Ultrasound
NORWALK, Conn.--(BUSINESS WIRE)--Vesselon announced an exclusive license with Temple University for patent enabling oncolytic viruses to be delivered systemically for solid tumors.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vesselon
Sign Up For FreeTo access detailed company insights
Vesselon specializes in developing patentable drug co-formulations that enhance the efficacy of therapeutic drugs through the use of FDA-approved lipid microspheres and self-assembling liposomes. Their innovative platform allows drug firms to extend the lifecycle of existing drugs, grow market share, and enable new indications without altering the... Read More
